Michael Boeckh Selected Research

P 11 (P-11)

12/2010	Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.
1/2007	Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients.
3/2002	Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Boeckh Research Topics

Disease

78	Infections 04/2024 - 01/2002
24	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2024 - 01/2003
20	Virus Diseases (Viral Diseases) 01/2024 - 12/2002
19	Human Influenza (Influenza) 01/2022 - 11/2004
16	Neutropenia 12/2022 - 02/2002
14	COVID-19 03/2024 - 01/2020
14	Cytomegalovirus Infections (Inclusion Disease) 11/2021 - 01/2002
13	Neoplasms (Cancer) 05/2024 - 09/2004
13	Respiratory Tract Infections (Respiratory Tract Infection) 04/2024 - 09/2004
13	Pneumonia (Pneumonitis) 01/2024 - 10/2003
13	Viremia 01/2023 - 03/2002
11	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023 - 07/2011
11	Aspergillosis 01/2021 - 07/2004
8	Communicable Diseases (Infectious Diseases) 05/2024 - 11/2017
8	Lymphopenia (Lymphocytopenia) 12/2020 - 12/2002
7	Respiratory Syncytial Virus Infections 12/2023 - 09/2004
7	Paramyxoviridae Infections (Parainfluenza) 01/2021 - 08/2009
6	Respiratory Insufficiency (Respiratory Failure) 01/2024 - 03/2006
6	Disease Progression 12/2022 - 05/2003
6	Bronchiolitis Obliterans Syndrome 01/2021 - 12/2002
5	Invasive Fungal Infections 07/2023 - 03/2009
5	Hematologic Neoplasms (Hematological Malignancy) 10/2022 - 03/2002
5	Leukemia 10/2022 - 10/2003
4	Critical Illness (Critically Ill) 01/2024 - 07/2008
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2023 - 08/2013
4	Herpes Zoster 01/2021 - 01/2015
4	Mycoses (Diseases, Fungus) 01/2015 - 02/2004
3	Hyperglycemia 01/2024 - 01/2021
3	Cytopenia 01/2022 - 12/2011
3	Herpes Simplex 11/2021 - 01/2015
3	Chickenpox 02/2015 - 11/2006
2	Diarrhea 05/2024 - 09/2013
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 08/2013
2	Hypoalbuminemia 12/2022 - 01/2022
2	Hepatitis C 11/2021 - 01/2021
2	Sepsis (Septicemia) 01/2021 - 01/2017
2	Measles 01/2021 - 10/2020
2	Renal Insufficiency (Renal Failure) 01/2020 - 10/2003
2	Bacteremia 01/2020 - 01/2017
2	Hemorrhagic Cystitis 01/2020 - 08/2005
2	Late Onset Disorders 01/2019 - 10/2008
2	Vomiting 12/2017 - 06/2008
2	Thrombocytopenia (Thrombopenia) 12/2013 - 12/2011
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2013 - 05/2006

Drug/Important Bio-Agent (IBA)

29	Antiviral Agents (Antivirals)IBA 03/2024 - 01/2002
14	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2003
12	Ganciclovir (Cytovene)FDA LinkGeneric 11/2021 - 01/2002
10	SteroidsIBA 01/2023 - 10/2003
9	RNA (Ribonucleic Acid)IBA 01/2024 - 05/2010
7	Oxygen (Dioxygen)IBA 01/2021 - 04/2013
5	VaccinesIBA 01/2022 - 04/2012
5	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2011 - 12/2002
4	maribavirIBA 01/2020 - 06/2008
3	Monoclonal AntibodiesIBA 05/2024 - 01/2022
3	Chimeric Antigen ReceptorsIBA 03/2024 - 01/2018
3	Viral DNAIBA 01/2024 - 08/2005
3	InterferonsIBA 01/2024 - 01/2023
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 10/2015
3	letermovirIBA 01/2021 - 12/2017
3	Ribavirin (Virazole)FDA LinkGeneric 12/2020 - 01/2007
3	Oseltamivir (Tamiflu)FDA Link 11/2020 - 11/2004
3	Valganciclovir FDA Link 01/2020 - 09/2003
3	Prednisone (Sone)FDA LinkGeneric 01/2020 - 03/2009
3	Acyclovir (Aciclovir)FDA LinkGeneric 03/2017 - 03/2003
3	Fluconazole (Zonal)FDA LinkGeneric 12/2010 - 02/2004
3	P 11 (P-11)IBA 12/2010 - 03/2002
2	Blood Glucose (Blood Sugar)IBA 01/2024 - 03/2009
2	Messenger RNA (mRNA)IBA 01/2024 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 10/2023 - 08/2004
2	CytokinesIBA 10/2023 - 07/2011
2	Cell-Free Nucleic AcidsIBA 07/2023 - 12/2021
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023 - 11/2022
2	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023 - 11/2022
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 05/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 11/2018
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
2	Valacyclovir (Valtrex)FDA LinkGeneric 01/2021 - 03/2017
2	oplunofuspIBA 01/2021 - 06/2015
2	presatovirIBA 12/2020 - 12/2020
2	AntibodiesIBA 01/2020 - 05/2019
2	Cidofovir (Vistide)FDA Link 01/2019 - 03/2005
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 11/2006
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2017
2	AzolesIBA 12/2016 - 09/2004
2	BilirubinIBA 07/2015 - 02/2007
2	AntigensIBA 09/2013 - 11/2003

Therapy/Procedure

61	Cell Transplantation 04/2024 - 12/2005
44	Therapeutics 03/2024 - 01/2002
42	Transplantation 04/2024 - 01/2002
15	Hematopoietic Stem Cell Transplantation 01/2020 - 05/2003
10	Artificial Respiration (Mechanical Ventilation) 12/2020 - 10/2003
7	Stem Cell Transplantation 03/2016 - 03/2002
6	Drug Therapy (Chemotherapy) 07/2023 - 02/2010
6	Immunotherapy 01/2023 - 01/2015
2	Glycemic Control 01/2024 - 01/2022
2	Homologous Transplantation 11/2021 - 06/2015
2	Mechanical Ventilators (Ventilator) 01/2021 - 01/2017
2	Self-Testing 01/2021 - 01/2020
2	Length of Stay 01/2017 - 07/2008
2	Highly Active Antiretroviral Therapy (HAART) 01/2017 - 09/2002